Cargando…
Phenelzine treatment increases transcription factor AP-2 levels in rat brain
BACKGROUND: The elevations of noradrenaline (NA) and serotonin (5-HT) levels in response to acute serotonin reuptake inhibitor (SSRI) or tricyclic antidepressant (TCA) exposure are not consistent with the time course for the therapeutic action of these antidepressants. Thus, neuronal adaptations are...
Autores principales: | Damberg, Mattias, Berggård, Cecilia, Oreland, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194722/ https://www.ncbi.nlm.nih.gov/pubmed/12943557 http://dx.doi.org/10.1186/1471-2210-3-10 |
Ejemplares similares
-
Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram
por: Berggard, Cecilia, et al.
Publicado: (2005) -
Does the transcription factor AP-2β have an impact on the genetic and early environmental influence on ethanol consumption?
por: Oreland, S., et al.
Publicado: (2010) -
Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice
por: Carpéné, Christian, et al.
Publicado: (2018) -
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
por: Matveychuk, Dmitriy, et al.
Publicado: (2021) -
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
por: Hinz, Marty, et al.
Publicado: (2014)